Cas:22312-62-5 2-Amino-N-(3-methylphenyl)benzamide manufacturer & supplier

Chemical Name:2-Amino-N-(3-methylphenyl)benzamide

CAS.NO:22312-62-5

Synonyms:anthranilic acid m-toluidide;2-Amino-N-m-tolyl-benzamide;Anthranilsaeure-m-toluidid;2-Amino-benzoesaeure-m-toluidid

Molecular Formula:C₁₄H₁₄N₂O

Molecular Weight:226.27400

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:324.1ºC at 760 mmHg

Density:1.21g/cm3

Index of Refraction:1.671

PSA:58.61000

Exact Mass:226.11100

LogP:3.79470

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like anthranilic acid m-toluidide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-benzoesaeure-m-toluidid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,anthranilic acid m-toluidide Use and application,2-Amino-N-m-tolyl-benzamide technical grade,usp/ep/jp grade.

Related News: The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 2-Amino-N-(3-methylphenyl)benzamide manufacturer The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 2-Amino-N-(3-methylphenyl)benzamide supplier The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market. 2-Amino-N-(3-methylphenyl)benzamide vendor The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 2-Amino-N-(3-methylphenyl)benzamide factory The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market.